Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains.

Cytotechnology

Balabashin D, Kovalenko E, Toporova V, Aliev T, Panina A, Svirshchevskaya E, Dolgikh D, Kirpichnikov M.
PMID: 24939591
Cytotechnology. 2015 Oct;67(5):761-72. doi: 10.1007/s10616-014-9714-3. Epub 2014 Jun 18.

Tumor necrosis factor-α (TNF-α) plays a key role in rheumatoid arthritis and some other autoimmune diseases. Therapy with anti-TNF-α recombinant antibodies (Ab) appears to be highly effective. Production of new hyper-producing eukaryotic cell lines can decrease the treatment cost,...

Cite
Balabashin D, Kovalenko E, Toporova V, et al. Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains. Cytotechnology. 2014;67(5):761-72doi: 10.1007/s10616-014-9714-3.
Balabashin, D., Kovalenko, E., Toporova, V., Aliev, T., Panina, A., Svirshchevskaya, E., Dolgikh, D., & Kirpichnikov, M. (2015). Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains. Cytotechnology, 67(5), 761-72. https://doi.org/10.1007/s10616-014-9714-3
Balabashin, Dmitriy, et al. "Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains." Cytotechnology vol. 67,5 (2015): 761-72. doi: https://doi.org/10.1007/s10616-014-9714-3
Balabashin D, Kovalenko E, Toporova V, Aliev T, Panina A, Svirshchevskaya E, Dolgikh D, Kirpichnikov M. Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains. Cytotechnology. 2015 Oct;67(5):761-72. doi: 10.1007/s10616-014-9714-3. Epub 2014 Jun 18. PMID: 24939591; PMCID: PMC4545435.
Copy Download .nbib Format: NLM
Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta.

Acta naturae

Panina AA, Rybchenko VS, Solopova ON, Balabashin DS, Yakimov SA, Aliev TK, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP.
PMID: 32742732
Acta Naturae. 2020 Apr-Jun;12(2):95-104. doi: 10.32607/actanaturae.10903.

The development of and research into new therapies that can selectively and effectively destroy tumor cells that overexpress the ErbB2 receptor is a pressing task. Recently, research into the use of type I interferons in the treatment of cancer...

Cite
Panina AA, Rybchenko VS, Solopova ON, et al. Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta. Acta Naturae. 2020;12(2):95-104doi: 10.32607/actanaturae.10903.
Panina, A. A., Rybchenko, V. S., Solopova, O. N., Balabashin, D. S., Yakimov, S. A., Aliev, T. K., Dolgikh, D. A., Sveshnikov, P. G., & Kirpichnikov, M. P. (2020). Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta. Acta naturae, 12(2), 95-104. https://doi.org/10.32607/actanaturae.10903
Panina, A A, et al. "Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta." Acta naturae vol. 12,2 (2020): 95-104. doi: https://doi.org/10.32607/actanaturae.10903
Panina AA, Rybchenko VS, Solopova ON, Balabashin DS, Yakimov SA, Aliev TK, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP. Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta. Acta Naturae. 2020 Apr-Jun;12(2):95-104. doi: 10.32607/actanaturae.10903. PMID: 32742732; PMCID: PMC7385087.
Copy Download .nbib Format: NLM
Bispecific Antibodies for IFN-β Delivery to ErbB2.

Biomolecules

Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP.
PMID: 34944558
Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915.

The main aim of our work was to create a full-length bispecific antibody (BsAb) as a vehicle for the targeted delivery of interferon-beta (IFN-β) to ErbB2

Cite
Rybchenko VS, Panina AA, Aliev TK, et al. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021;11(12)doi: 10.3390/biom11121915.
Rybchenko, V. S., Panina, A. A., Aliev, T. K., Solopova, O. N., Balabashin, D. S., Novoseletsky, V. N., Dolgikh, D. A., Sveshnikov, P. G., & Kirpichnikov, M. P. (2021). Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules, 11(12), . https://doi.org/10.3390/biom11121915
Rybchenko, Vladislav S, et al. "Bispecific Antibodies for IFN-β Delivery to ErbB2." Biomolecules vol. 11,12 (2021). doi: https://doi.org/10.3390/biom11121915
Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915. PMID: 34944558; PMCID: PMC8699518.
Copy Download .nbib Format: NLM
Bispecific Antibodies for IFN-β Delivery to ErbB2.

Biomolecules

Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP.
PMID: 34944558
Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915.

The main aim of our work was to create a full-length bispecific antibody (BsAb) as a vehicle for the targeted delivery of interferon-beta (IFN-β) to ErbB2

Cite
Rybchenko VS, Panina AA, Aliev TK, et al. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021;11(12)doi: 10.3390/biom11121915.
Rybchenko, V. S., Panina, A. A., Aliev, T. K., Solopova, O. N., Balabashin, D. S., Novoseletsky, V. N., Dolgikh, D. A., Sveshnikov, P. G., & Kirpichnikov, M. P. (2021). Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules, 11(12), . https://doi.org/10.3390/biom11121915
Rybchenko, Vladislav S, et al. "Bispecific Antibodies for IFN-β Delivery to ErbB2." Biomolecules vol. 11,12 (2021). doi: https://doi.org/10.3390/biom11121915
Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915. PMID: 34944558.
Copy Download .nbib Format: NLM
Recombinant Antibodies to the Ebola Virus Glycoprotein.

Acta naturae

Panina AA, Dementieva IG, Aliev TK, Toporova VA, Balabashin DS, Bokov MN, Pozdnyakova LP, Shchemchukova OB, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP.
PMID: 29340221
Acta Naturae. 2017 Oct-Dec;9(4):84-91.

Currently, there are no approved therapies for targeted prevention and treatment of Ebola hemorrhagic fever. In the present work, we describe the development of a eukaryotic expression system for the production of three full-length chimeric antibodies (IgG1-kappa isotypes) GPE118,...

Cite
Panina AA, Dementieva IG, Aliev TK, et al. Recombinant Antibodies to the Ebola Virus Glycoprotein. Acta Naturae. 2017;9(4):84-91
Panina, A. A., Dementieva, I. G., Aliev, T. K., Toporova, V. A., Balabashin, D. S., Bokov, M. N., Pozdnyakova, L. P., Shchemchukova, O. B., Dolgikh, D. A., Sveshnikov, P. G., & Kirpichnikov, M. P. (2017). Recombinant Antibodies to the Ebola Virus Glycoprotein. Acta naturae, 9(4), 84-91.
Panina, A A, et al. "Recombinant Antibodies to the Ebola Virus Glycoprotein." Acta naturae vol. 9,4 (2017): 84-91.
Panina AA, Dementieva IG, Aliev TK, Toporova VA, Balabashin DS, Bokov MN, Pozdnyakova LP, Shchemchukova OB, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP. Recombinant Antibodies to the Ebola Virus Glycoprotein. Acta Naturae. 2017 Oct-Dec;9(4):84-91. PMID: 29340221; PMCID: PMC5762832.
Copy Download .nbib Format: NLM
Targeting Extracellular Vesicles to Dendritic Cells and Macrophages.

Acta naturae

Ovchinnikova LA, Filimonova IN, Zakharova MY, Balabashin DS, Aliev TK, Lomakin YA, Gabibov AG.
PMID: 34707904
Acta Naturae. 2021 Jul-Sep;13(3):114-121. doi: 10.32607/actanaturae.11478.

Targeting protein therapeutics to specific cells and tissues is a major challenge in modern medicine. Improving the specificity of protein therapeutic delivery will significantly enhance efficiency in drug development. One of the promising tools for protein delivery is extracellular...

Cite
Ovchinnikova LA, Filimonova IN, Zakharova MY, et al. Targeting Extracellular Vesicles to Dendritic Cells and Macrophages. Acta Naturae. 2021;13(3):114-121doi: 10.32607/actanaturae.11478.
Ovchinnikova, L. A., Filimonova, I. N., Zakharova, M. Y., Balabashin, D. S., Aliev, T. K., Lomakin, Y. A., & Gabibov, A. G. (2021). Targeting Extracellular Vesicles to Dendritic Cells and Macrophages. Acta naturae, 13(3), 114-121. https://doi.org/10.32607/actanaturae.11478
Ovchinnikova, L A, et al. "Targeting Extracellular Vesicles to Dendritic Cells and Macrophages." Acta naturae vol. 13,3 (2021): 114-121. doi: https://doi.org/10.32607/actanaturae.11478
Ovchinnikova LA, Filimonova IN, Zakharova MY, Balabashin DS, Aliev TK, Lomakin YA, Gabibov AG. Targeting Extracellular Vesicles to Dendritic Cells and Macrophages. Acta Naturae. 2021 Jul-Sep;13(3):114-121. doi: 10.32607/actanaturae.11478. PMID: 34707904; PMCID: PMC8526189.
Copy Download .nbib Format: NLM
Bispecific Antibodies for IFN-β Delivery to ErbB2.

Biomolecules

Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP.
PMID: 34944558
Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915.

The main aim of our work was to create a full-length bispecific antibody (BsAb) as a vehicle for the targeted delivery of interferon-beta (IFN-β) to ErbB2

Cite
Rybchenko VS, Panina AA, Aliev TK, et al. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021;11(12)doi: 10.3390/biom11121915.
Rybchenko, V. S., Panina, A. A., Aliev, T. K., Solopova, O. N., Balabashin, D. S., Novoseletsky, V. N., Dolgikh, D. A., Sveshnikov, P. G., & Kirpichnikov, M. P. (2021). Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules, 11(12), . https://doi.org/10.3390/biom11121915
Rybchenko, Vladislav S, et al. "Bispecific Antibodies for IFN-β Delivery to ErbB2." Biomolecules vol. 11,12 (2021). doi: https://doi.org/10.3390/biom11121915
Rybchenko VS, Panina AA, Aliev TK, Solopova ON, Balabashin DS, Novoseletsky VN, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP. Bispecific Antibodies for IFN-β Delivery to ErbB2. Biomolecules. 2021 Dec 20;11(12). doi: 10.3390/biom11121915. PMID: 34944558; PMCID: PMC8699518.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries